Synthesis and Characterization of Histone Deacetylase (HDAC) Inhibitors and PROTACs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bonn, Rheinische Friedrich-Wilhelms-Universität, Dissertation, 2024
- Schlagwort
-
Enzyminhibitor
Inhibitor
Chemische Synthese
- Ereignis
-
Veröffentlichung
- (wo)
-
Bonn
- (wer)
-
Universitäts- und Landesbibliothek Bonn
- (wann)
-
2024
- Urheber
-
Kraft, Fabian
- Beteiligte Personen und Organisationen
-
Hansen, Finn K.
Bendas, Gerd
- Handle
-
20.500.11811/11657
- URN
-
urn:nbn:de:hbz:5-76956
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kraft, Fabian
- Hansen, Finn K.
- Bendas, Gerd
- Universitäts- und Landesbibliothek Bonn
Entstanden
- 2024
Ähnliche Objekte (12)
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production
Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Development of class IIa histone deacetylase inhibitors
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production
Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Development of class IIa histone deacetylase inhibitors
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production
Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10